Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Isopropyl Alcohol→

Isopropyl Alcohol Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
67-63-0
Molecular formula
C3H8O
Molecular weight
60.095 g/mol
Drug class
Alcohol antiseptic and disinfectanttopical antimicrobial agent
Mechanism of action
Denatures microbial proteins and disrupts cell membranes. It is rapidly bactericidal against vegetative bacteria and also has fungicidal and activity against many viruses, but it does not reliably destroy bacterial spores.
Indications / reported uses
  • Skin antisepsis before injections, venepuncture and selected procedures using appropriately formulated alcohol preparations.
  • Disinfection of small non-critical surfaces and equipment where approved for the material and application.

Sources: https://www.cdc.gov/infection-control/hcp/disinfection-sterilization/chemical-disinfectants.html · https://www.cdc.gov/infection-control/media/pdfs/guideline-disinfection-h.pdf · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Isopropyl Alcohol Environmental Risk Assessment (ERA) (the Isopropyl Alcohol ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.